Chai Discovery secured a $70 million Series A to revolutionize the prediction and reprogramming of biochemical molecule interactions. The new funding is set to accelerate its cutting‐edge AI models for therapeutic development and position the company as a serious contender in the competitive health tech landscape.
Back to Top / Thursday, August 7, 2025, 2:21 pm / permalink 11869 / 1 stories in 6 months
Massive AI Investment Set to Transform Pittsburgh / 7 months
Stability AI and Arm Unveil Innovative On-Device Audio Generating Model / 9 months
Gosta Labs Lands €7.5M Seed Round for AI Oncology Platform / 3 months
SpaceX invests $2B in Elon Musk’s AI lab xAI push / 7 months
Meta Eyes Billions Investment in AI Data Labeling Startup Scale AI / 8 months
Microsoft Build 2025 Focuses on AI Innovations and Developer Tools / 9 months
Gradium Raises $70M Seed Round for Voice AI Innovation / 3 months
NorthFeed Inc.
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.